Skip Ribbon Commands
Skip to main content
We are currently experiencing intermittent issues impacting registration and login including access to online learning. We apologize for any inconvenience.
PHO Rounds: Microbiology: Zika virus. Epidemiology, clinical features, laboratory testing and management of the pregnant patient
Wednesday, February 24, 2016 02:00 pm to 03:00 pm
Venue: by webinar
Infectious Diseases; Emergency Preparedness; Health Promotion; Laboratory Testing and Sciences
City: Toronto
Type: PHO Rounds: Microbiology
Format: Webinar

​Note: This is an open invitation, and may be forwarded to interested parties.

There are a myriad of challenges and uncertainties associated with the emergence of Zika virus (ZIKV) infection in Central/South America and the Caribbean.  The following topics will be presented and discussed:

• The evolving epidemiology of ZIKV infections, with associated challenges related to modes of transmission, incidence, risk factors and clinical spectrum of illness;
• Diagnostic recommendations and their associated challenges;
• Challenges associated with managing a pregnant woman at risk of or infected with Zika virus;
• The etiology of potential ZIKV complications, especially microcephaly/congenital birth defects and Guillain-Barre Syndrome;
• Efforts to develop a Zika virus vaccine.

DISCLAIMER: The opinions expressed by speakers and moderators do not necessarily reflect the official policies or views of Public Health Ontario, nor does the mention of trade names, commercial practices, or organizations imply endorsement by Public Health Ontario.

Presenters: Dr. Kellie Murphy, Dr. Jonathan Gubbay and Dr. Doug Sider

Dr. Kellie Murphy completed her obstetrical residency program at Albert Einstein College of Medicine in New York City in 1995.  She then completed a Maternal-Fetal Medicine fellowship program and a Master of Epidemiology at Columbia Presbyterian Medical Center and School of Public Health in New York.  In July of 1998, she joined the department of Obstetrics and Gynecology at the University of Toronto where she is currently an Associate Professor, based out of Mount Sinai Hospital. 

Doug Sider is a public health and preventive medicine specialist who serves as Medical Director for Communicable Disease Prevention and Control at Public Health Ontario, where he has an operational and research focus on vector-borne diseases.  He has had extensive experience at the local public health unit level, co-chaired the Provincial Infectious Diseases Advisory Committee from 2005-2009, and is an assistant professor in McMaster University’s Department of Clinical Epidemiology and Biostatistics.

Jonathan Gubbay is the medical microbiologist for the virus detection, arboviruses and respiratory bacteriology laboratories at PHO, and is the laboratory lead for emerging viral pathogens at PHO laboratories. He is an assistant professor in the Departments of Laboratory Medicine and Pathobiology and Pediatrics at the University of Toronto and part time staff physician in the Division of Infectious Diseases, The Hospital for Sick Children. He has a research interest in the molecular epidemiology and diagnosis of respiratory viral infections and emergence of antiviral resistance.

PLEASE NOTE: We regret that CME credits cannot be provided for this session.

For more information, contact


Stay up-to-date on upcoming events and calls for abstracts by visiting our calendar.
If you have submissions, or questions or comments about the items above, send them to

Public Health Ontario is committed to complying with the Accessibility for Ontarians with Disabilities Act (AODA).
If you require accommodations to participate in this event, please contact 647-260-7100 or

Uncontrolled print copy. Valid only on day of Print: [date]
Page updated on [date/time] 2016-02-17 2:31 PM
© , Ontario Agency for Health Protection and Promotion